Evidence map›Paper›PMID 35263682›Full record

Observational studyThe journal of allergy and clinical immunology. In practice2022

Transition to Virtual Asthma Care During the COVID-19 Pandemic: An Observational Study.

Peter J Cvietusa, Glenn K Goodrich, John F Steiner, Jo Ann Shoup, Diane K King, Debra P Ritzwoller, Susan M Shetterly, Bruce G Bender

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in The journal of allergy and clinical immunology. In practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  2. Impact of the COVID-19 pandemic on adult asthma-related health care utilization.The journal of allergy and clinical immunology. Global · 2026
    Article
  3. Air Quality Index as a Predictor of Respiratory Morbidity in At-Risk Populations.International journal of environmental research and public health · 2025
    Article
  4. Impact of the COVID-19 Pandemic on Adult Asthma-Related Healthcare Utilization.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Trends in telemedicine visits among pediatric asthma patients during COVID-19.The journal of allergy and clinical immunology. Global · 2024
    Article
  11. Hypertension care during the COVID-19 pandemic in an integrated health care system.Journal of clinical hypertension (Greenwich, Conn.) · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Peter J CvietusaInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo; Department of Asthma, Allergy, and Immunology, Permanente Medical Group, Denver, Colo. Electronic address: Peter.J.Cvietusa@kp.org.
Glenn K GoodrichInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
John F SteinerInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Jo Ann ShoupInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Diane K KingCenter for Behavioral Health Research and Services, Institute of Social and Economic Research, University of Alaska Anchorage, Anchorage, Alaska.
Debra P RitzwollerInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Susan M ShetterlyInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Bruce G BenderDivision of Pediatric Behavioral Health, National Jewish Health, Denver, Colo.
Kaiser Permanente · USColorado Permanente Medical Group · USNational Jewish Health · USUniversity of Alaska Anchorage · US

Funding

The Breathewell Program to Improve Asthma OutcomesR01HL126125 · NHLBI · NATIONAL JEWISH HEALTH · PI BENDER, BRUCE GEORGE · 2015 to 2019
$3.3M
NHLBI NIH HHS R01 HL126125
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic increased reliance on virtual care for patients with persistent asthma.

objectiveThis retrospective cohort study assessed changes from in-person to virtual care during the pandemic. In patients with persistent asthma, compared with the same period before the pandemic.

methodsKaiser Permanente Colorado members aged 18 to 99 years with persistent asthma were evaluated during two periods (March to October 2019 and March to October 2020). Comparison of asthma exacerbations (hospitalizations, emergency department visits, and courses of oral prednisone) and asthma medication metrics were evaluated between the two periods and by type of care received during the pandemic (no care, virtual care only, in-person care only, or a mix of virtual and in-person care). Population characteristics by type of care received during the pandemic were also evaluated.

resultsAmong 7,805 adults with persistent asthma, those who used more virtual care or sought no care during the pandemic were younger and had fewer comorbidities, mental health diagnoses, or financial barriers. Exacerbations decreased (0.264 to 0.214; P <.001) as did courses of prednisone (0.213 to 0.169). Asthma medication adherence (0.53 to 0.54; P <.001) and the asthma medication ratio, a quality-of-care metric (0.755 to 0.762; P = .019), increased slightly. Patients receiving a mix of in-person and virtual care had the highest rate of exacerbations (0.83) and a lower asthma medication ratio (0.74) despite having the highest adherence (.57).

conclusionsDespite an increase in virtual care, asthma exacerbations decreased except among individuals who received both in-person and virtual care, likely because they had more severe disease.

Indexed as

Anti-Asthmatic AgentsAsthmaCOVID-19TelemedicineAdultHumansPandemicsPrednisoneRetrospective StudiesAnti-Asthmatic AgentsPrednisoneAsthma exacerbationsCOVID-19 pandemicPersistent asthmaTelemedicineVirtual asthma care

Identifiers

PMID35263682
PMCPMC8898589
OpenAlexW4220669815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.